Clik here to view.
パスウェイ・ゲノミクスがFDAの承認を受けた次世代シーケンシングシステムIllumina MiSeqDxを追加
サンディエゴ （ビジネスワイヤ） — サンディエゴに拠点を置き、CLIAおよびCAPの認定を受けて遺伝子検査サービスを世界規模で提供している臨床ラボラトリーのパスウェイ・ゲノミクス・コーポレーションは本日、当社の一連の次世代シーケンシングシステムにIllumina MiSeqDxを追加したと発表しました。...
View ArticleClik here to view.
BeiGene Announces Addition of Dr. Ronald Levy to Scientific Advisory Board
BEIJING BeiGene (Beijing), Co., Ltd., an innovative oncology company focused on developing targeted and immune-oncology therapeutics, today announced the addition of Dr. Ronald Levy, M.D., to its...
View ArticleClik here to view.
BioTime Provides Financing and Product Development Update
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) today announced the results of its capital raising activities since October 1, 2013 through its $25 million Controlled Equity Offering facility, and...
View ArticleClik here to view.
BSD Medical Reports on Continued Sales Momentum by Terumo for the...
SALT LAKE CITY BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today...
View ArticleClik here to view.
Verastem Reports Data from Phase 1 Study of VS-6063 (defactinib) in Japanese...
CAMBRIDGE, Mass. Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today presented preliminary data from an...
View ArticleClik here to view.
日本人患者を対象にした VS-6063 ( defactinib ) の第1相試験のデータをVerastem社が発表
米国マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — がん幹細胞の選択的殺傷によるがん治療の薬剤開発を中心に行っているVerastem 社 ( NASDAQ: VSTM ) は本日、日本人患者を対象に行われている VS-6063 ( defactinib )...
View ArticleClik here to view.
CORE Diagnostics Appoints New CEO to Accelerate Growth
PALO ALTO, Calif. CORE Diagnostics, Inc., the leading high-end clinical diagnostics laboratory, announced today the appointment of K. Balachandran (Bala) as chief executive officer, effective...
View ArticleClik here to view.
eMallFashion Supports The National Breast Cancer Foundation’s Goal of Zero...
SYDNEY eMallFashion.com, the totally free online marketplace for retailers, is inviting its customers and sellers to support The National Breast Cancer Foundation (NBCF) through its fundraising...
View ArticleClik here to view.
Transgene Announces Presentation of Data on TG1050 Immunotherapy against...
STRASBOURG, France Regulatory News: Transgene (Paris:TNG) today announced that it was invited to present existing preclinical data on its proprietary program against chronic hepatitis B, TG1050...
View ArticleClik here to view.
Clik here to view.
癌症个性化医疗WIN联盟在WIN 2014研讨会上欢迎六家新成员加入
法国维勒瑞夫 (美国商业资讯)–癌症个性化医疗的全球创新网络(Worldwide Innovative Networking, WIN)联盟自豪地宣布，在6月23日至24日于法国巴黎举办的2014 WIN研讨会(2014 WIN Symposium)期间有六家组织获批成为该联盟新成员。新加入该联盟的组织为：韩国峨山医学中心(Asan Medical...
View ArticleClik here to view.
Incyte Achieves $25 Million Milestone for Approval of Jakavi® (ruxolitinib)...
WILMINGTON, Del. Incyte Corporation (Nasdaq: INCY) announced today that it has earned a $25 million milestone payment from Novartis in connection with the approval of Jakavi® (ruxolitinib) in Japan...
View ArticleClik here to view.
Celgene报告评估Oral OTEZLA®用于强直性脊柱炎的III期POSTURE研究结果
新泽西州萨米特 Celgene Corporation (NASDAQ:CELG)今天发布了该公司的III期POSTURE研究结果，该研究评估该公司的磷酸二酯酶4...
View ArticleClik here to view.
Biosceptre Closes AUD5m Financing from Existing Investors
CAMBRIDGE, England Biosceptre International Limited, the oncology company developing antibody products that target the nf-P2X7 receptor, today announced that it has raised AU$5m through a syndicate...
View ArticleClik here to view.
New Bone Marrow Transplantation Technique Offered in Thailand by Phyathai 2...
BANGKOK Bone marrow transplantation used to require a donor who is the recipient’s sibling, parent or child with 50% HLA matching. At the Oncology Center of Phyathai 2 International Hospital, a new,...
View ArticleClik here to view.
Clik here to view.
BioTime Announces Issuance of 14 Patents in the Fields of Regenerative...
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT:BTX) announced today the issuance of 14 new patents to BioTime and its subsidiary companies. The patents issued in Australia, Canada, China, Japan, and the...
View ArticleClik here to view.
Theorem Clinical Research and Excel Life Sciences Form Strategic Relationship
KING OF PRUSSIA, Pa. Theorem Clinical Research and Excel Life Sciences (ELS) have formed a strategic relationship to bolster Theorem’s clinical development offerings in India, including local site...
View ArticleClik here to view.
CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka
VIENNA, Va. CEL-SCI Corporation (NYSE MKT:CVM) today announced that Sri Lanka’s Ministry of Health has cleared the Company to commence patient enrollment for its Phase III Head and Neck Cancer...
View ArticleClik here to view.
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing...
BEIJING & SAN DIEGO Berry Genomics Co. Ltd. announced today it has chosen Illumina Inc’s. (NASDAQ: ILMN) next-generation sequencing (NGS) technology as the platform on which Berry will secure...
View Article